Published in Obstet Gynecol on March 01, 1985
Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer (1992) 1.96
Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst (1996) 1.93
Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol (1995) 1.85
Rapid detection of rotavirus in stool by latex agglutination: comparison with radioimmunoassay and electron microscopy and clinical evaluation of the test. J Med Virol (1983) 1.84
Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer (1994) 1.76
Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg (1983) 1.65
Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis (1994) 1.61
Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes. J Virol Methods (1988) 1.58
Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol (2001) 1.52
Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril (1996) 1.47
Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease. Prenat Diagn (1996) 1.46
Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer (2009) 1.44
Medical student abuse: an international phenomenon. JAMA (1994) 1.41
Reproductive performance of women with uterine anomalies. An evaluation of 182 cases. Acta Obstet Gynecol Scand (1982) 1.41
Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer. Acta Cytol (2000) 1.41
Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer (1994) 1.40
Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol (1999) 1.38
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33
Weights of placentae from small-for-gestational age infants revisited. Placenta (2001) 1.32
Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol (1983) 1.31
Maternal antibodies in human foetal sera at different stages of gestation. Immunology (1968) 1.29
Transgenic mice aberrantly expressing human ornithine decarboxylase gene. J Biol Chem (1991) 1.29
Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol (1994) 1.27
High and unchanged sperm counts of Finnish men. Int J Androl (1996) 1.27
Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol (1992) 1.26
Bone mineral density and risk factors for osteoporosis--a population-based study of 1600 perimenopausal women. Calcif Tissue Int (1994) 1.24
Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridisation. Genitourin Med (1993) 1.23
Report on consensus conference on cervical cancer screening and management. Int J Cancer (2000) 1.20
Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur J Epidemiol (1989) 1.20
Human papillomavirus (HPV) DNA sequences demonstrated by in situ DNA hybridization in serial paraffin-embedded cervical biopsies. Arch Gynecol (1986) 1.20
Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol (1997) 1.18
Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol (1996) 1.17
Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD AIDS (2003) 1.17
Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis (1990) 1.17
Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer (1993) 1.16
The influence of perinatal factors on breast feeding. Acta Paediatr Scand (1983) 1.16
Squamous cell carcinoma of the conjunctiva. Failure to demonstrate HPV DNA by in situ hybridization and polymerase chain reaction. Acta Ophthalmol (Copenh) (1992) 1.14
Cervical papillomavirus infection progressing to invasive cancer in less than three years. Lancet (1985) 1.13
Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res (1994) 1.13
Hormone receptors as prognostic factors in female breast cancer. Ann Med (1991) 1.12
An improved in situ DNA hybridization protocol for detection of human papillomavirus (HPV) DNA sequences in paraffin-embedded biopsies. J Virol Methods (1986) 1.10
Infectious agents in the etiology of esophageal cancer. Gastroenterology (1992) 1.10
Malignant fibrous histiocytoma of the vulva. Gynecol Oncol (1987) 1.10
Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporos Int (2004) 1.10
Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol (1993) 1.10
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer. Gynecol Oncol (2006) 1.09
Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up. Br J Obstet Gynaecol (1985) 1.09
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer (2000) 1.09
The effect of gynecological risk factors on lumbar and femoral bone mineral density in peri- and postmenopausal women. Maturitas (1995) 1.09
The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. J Cancer Res Clin Oncol (1996) 1.08
Random amplified polymorphic DNA genotyping of Mycobacterium malmoense. J Clin Microbiol (1994) 1.06
Birth weight and sex of children and the correlation to the body burden of PCDDs/PCDFs and PCBs of the mother. Environ Health Perspect (1998) 1.06
Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis (1984) 1.05
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. J Clin Oncol (1998) 1.05
Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis (1997) 1.05
Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis (1992) 1.05
Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. Br J Cancer (1994) 1.04
Extrinsic allergic alveolitis in the tobacco industry. Br J Ind Med (1984) 1.04
Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol (1999) 1.04
Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol (1994) 1.03
Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet (2000) 1.03
PCDD, PCDF, and PCB concentrations in human milk from two areas in Finland. Chemosphere (1997) 1.03
Risk factors for perimenopausal fractures: a prospective study. Osteoporos Int (2000) 1.03
Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy. Genitourin Med (1991) 1.02
Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol (1995) 1.02